TennCare - As introduced, requires a TennCare health benefit plan renewed or issued on or after July 1, 2025, by a health insurance carrier to provide coverage and reimbursement for biomarker testing for preeclampsia in pregnant women. - Amends TCA Title 56; Title 63; Title 68 and Title 71.

HB 70 requires TennCare health benefit plans (renewed or issued on or after July 1, 2025) to cover and reimburse biomarker testing for preeclampsia in pregnant women. This directly affects pregnant women enrolled in Tennessee's Medicaid program (TennCare) and the health insurance carriers providing their coverage. The bill mandates that testing must be ordered by a physician, conducted by the prenatal care provider using FDA-approved methods, and follow clinical guidelines. It also allows TennCare to create rules and seek federal approval to ensure Medicaid coverage for this testing.